Gokaldas Exports Limited (NSE:GOKEX)
India · Delayed Price · Currency is INR 715.40
-7.15 (-0.99%)
Aug 8, 2025, 3:29 PM IST
Revance Therapeutics Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Net Income | - | 1,585 | 1,310 | 1,730 | 1,171 | 264.92 | Upgrade |
Depreciation & Amortization | - | 1,284 | 870.87 | 695.64 | 572.91 | 509.88 | Upgrade |
Other Amortization | - | - | 16.87 | 21.87 | 16.57 | 16.27 | Upgrade |
Loss (Gain) From Sale of Assets | - | -0.78 | -4.18 | -1.93 | -6.06 | -6.14 | Upgrade |
Loss (Gain) From Sale of Investments | - | -287.35 | -261.02 | -158.95 | -27.92 | -14.38 | Upgrade |
Stock-Based Compensation | - | 250.76 | 241.88 | 229.8 | 13.58 | 52.03 | Upgrade |
Provision & Write-off of Bad Debts | - | 6.67 | 35.9 | 2.77 | 0.81 | 81.38 | Upgrade |
Other Operating Activities | - | 818.58 | 33.01 | 61.17 | 181.24 | 271.1 | Upgrade |
Change in Accounts Receivable | - | -648.21 | -2,148 | -464.67 | 876.78 | -466.51 | Upgrade |
Change in Inventory | - | -783.39 | -3,106 | 1,406 | -1,744 | 300.4 | Upgrade |
Change in Accounts Payable | - | 382.78 | 953.72 | -338.32 | 284.31 | -3.24 | Upgrade |
Change in Other Net Operating Assets | - | -2,037 | 287.14 | 504.91 | -166.87 | 181.37 | Upgrade |
Operating Cash Flow | - | 571.96 | -1,771 | 3,688 | 1,172 | 1,187 | Upgrade |
Operating Cash Flow Growth | - | - | - | 214.70% | -1.27% | 20.39% | Upgrade |
Capital Expenditures | - | -1,909 | -6,891 | -1,354 | -798.11 | -362.21 | Upgrade |
Sale of Property, Plant & Equipment | - | 28.9 | 10.93 | 89.85 | 15.92 | 21.43 | Upgrade |
Investment in Securities | - | -2,376 | 1,472 | -1,679 | 171 | -77.8 | Upgrade |
Other Investing Activities | - | 49.02 | 33.64 | 30.26 | 88.27 | 96.36 | Upgrade |
Investing Cash Flow | - | -4,207 | -5,374 | -2,914 | -522.92 | -322.22 | Upgrade |
Short-Term Debt Issued | - | - | - | - | - | 16,833 | Upgrade |
Long-Term Debt Issued | - | 15,532 | 13,283 | 4,148 | 21,142 | - | Upgrade |
Total Debt Issued | - | 15,532 | 13,283 | 4,148 | 21,142 | 16,833 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -17,109 | Upgrade |
Long-Term Debt Repaid | - | -16,171 | -7,941 | -4,847 | -24,247 | -300.83 | Upgrade |
Total Debt Repaid | - | -16,171 | -7,941 | -4,847 | -24,247 | -17,410 | Upgrade |
Net Debt Issued (Repaid) | - | -639.14 | 5,342 | -699.08 | -3,105 | -577.07 | Upgrade |
Issuance of Common Stock | - | 5,969 | 2,475 | 43.15 | 2,926 | 0.35 | Upgrade |
Common Dividends Paid | - | - | -60.61 | - | - | - | Upgrade |
Other Financing Activities | - | -595.38 | -224.44 | -98.39 | -251.12 | -285.61 | Upgrade |
Financing Cash Flow | - | 4,735 | 7,532 | -754.32 | -430.17 | -862.32 | Upgrade |
Foreign Exchange Rate Adjustments | - | 5.4 | 7.69 | - | - | - | Upgrade |
Net Cash Flow | - | 1,105 | 395.26 | 20.4 | 218.89 | 2.54 | Upgrade |
Free Cash Flow | - | -1,337 | -8,661 | 2,334 | 373.87 | 824.87 | Upgrade |
Free Cash Flow Growth | - | - | - | 524.28% | -54.68% | 35.56% | Upgrade |
Free Cash Flow Margin | - | -3.46% | -36.41% | 10.50% | 2.09% | 6.81% | Upgrade |
Free Cash Flow Per Share | - | -18.09 | -135.60 | 36.70 | 7.07 | 18.16 | Upgrade |
Cash Interest Paid | - | 595.38 | 224.44 | 98.39 | 251.12 | 285.61 | Upgrade |
Cash Income Tax Paid | - | 461.28 | 412.48 | 384.66 | 134.32 | -26.01 | Upgrade |
Levered Free Cash Flow | - | -2,346 | -7,397 | 2,033 | -268.43 | 68.28 | Upgrade |
Unlevered Free Cash Flow | - | -1,862 | -7,232 | 2,139 | -78.04 | 246.05 | Upgrade |
Change in Net Working Capital | - | 2,931 | 2,495 | -1,344 | 667.1 | 285.11 | Upgrade |
Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.